Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen

Aaron Goodman recently shared a post on X/Twitter:

“Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen. Here it is described with other thyroid abnormalities with second-generation Tyrosine kinase inhibitors (TKIs).”

Read further.

Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.